{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:46:50Z","timestamp":1783547210226,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The mesial temporal lobe plays a distinct role in epileptogenesis, and tumors in this part of the brain potentially have specific clinical and radiological features. Differentiating high-grade from lower-grade tumors or non-neoplastic lesions can be challenging, preventing the decision for early resection that can be critical in high-grade tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A brain tumor database was analyzed retrospectively to identify patients with temporomesial tumors. We determined clinical features (age, sex, symptoms leading to clinical presentation) as well as neuroradiological (tumor location and the presence of contrast enhancement on initial magnetic resonance imaging (MRI)) and neuropathological findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 324 temporal tumors. 39 involved the mesial temporal lobe. 77% of temporomesial tumors occured in males, and 77% presented with seizures, regardless of tumor type or grade. In patients 50 years or older, 90% were male and 80% had glioblastoma (GBM); there was no GBM in patients younger than 50 years. 50% of GBMs lacked contrast enhancement. Male sex was significantly associated with GBM. In both contrast-enhancing and non-enhancing tumors, age of 50 years or older was also significantly associated with GBM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In middle-aged and older patients with a mesial temporal lobe tumor, GBM is the most likely diagnosis even when there is no MRI contrast enhancement. Prolonged diagnostic workup or surveillance strategies should be avoided and early resection may be justified in these patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1236269","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T14:49:47Z","timestamp":1693234187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical, radiological and pathological features of temporomesial tumors in the adult. A single center experience from 15 years"],"prefix":"10.3389","volume":"13","author":[{"given":"Hanno S.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Wiestler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa S.","family":"H\u00f6nikl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Delbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Ketterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gempt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2016.10.001","article-title":"Biomarkers related with seizure risk in glioma patients: A systematic review","volume":"151","author":"Zhou","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101349","article-title":"Epileptogenesis and tumorigenesis in glioblastoma: which relationship","volume":"58","author":"Rossi","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac207","article-title":"Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions","volume":"25","author":"Miller","year":"2022","journal-title":"Neuro-oncology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00090-5","article-title":"Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study","volume":"22","author":"van den Bent","year":"2021","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.12807","article-title":"Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas","volume":"308","author":"Jakola","year":"2012","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500925","article-title":"Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma","volume":"374","author":"Buckner","year":"2016","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03513-9","article-title":"Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma","volume":"148","author":"Mair","year":"2020","journal-title":"J neuro-oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx230","article-title":"Surgical resection versus watchful waiting in low-grade gliomas","volume":"28","author":"Jakola","year":"2017","journal-title":"Ann Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061579","article-title":"Personalized treatment of glioblastoma: current state and future perspective","volume":"11","author":"Roncevic","year":"2023","journal-title":"Biomedicines"},{"key":"B13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta neuropathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta neuropathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1370-3","article-title":"ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an \u201cintegrated\u201d diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma","volume":"129","author":"Reuss","year":"2015","journal-title":"Acta neuropathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.54.10.1886","article-title":"Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"Glantz","year":"2000","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other Malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003911","article-title":"Mutant IDH1 and seizures in patients with glioma","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32708","article-title":"Seizures in patients with cancer","volume":"126","author":"Gonzalez Castro","year":"2020","journal-title":"Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos199","article-title":"Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments","author":"Ruda","year":"2012","journal-title":"Neuro-oncology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v2.i11.623","article-title":"Epilepsy associated tumors: Review article","volume":"2","author":"Giulioni","year":"2014","journal-title":"World J Clin cases"},{"key":"B24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-014-1288-9","article-title":"neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors","volume":"128","author":"Blumcke","year":"2014","journal-title":"Acta neuropathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-014-1301-3","article-title":"Pathology-based approach to epilepsy surgery","volume":"128","author":"Blumcke","year":"2014","journal-title":"Acta neuropathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2003.56102.x","article-title":"The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects","volume":"44","author":"Luyken","year":"2003","journal-title":"Epilepsia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro-oncology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1236269\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T14:49:55Z","timestamp":1693234195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1236269\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":27,"alternative-id":["10.3389\/fonc.2023.1236269"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1236269","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"article-number":"1236269"}}